Skip to main content

Walbert Timothy P's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed May 13, 2022

Accession no.
0001209191-22-028884
Filed
May 13, 2022
Trade date
May 11, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.58M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walbert Timothy PCIK 0001349376Director, Officer (Chairman, President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 11, 2022Ordinary SharesMOption exerciseAcquired+17,600$22.14+$389,664478,149Direct
May 11, 2022Ordinary SharesSSaleDisposed−17,600$90.00−$1,584,000460,549Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 11, 2022Ordinary SharesMOption exerciseDisposed−17,600$0.00$0792,565Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)